Lecturer Will Discuss Replacing Drugs with Electronic Devices

Kevin J. Tracey, MD

/kidneynews/8_10_11/31a/graphic/31af1.jpg

Reflex Circuits in Immunity: Bioelectronic Medicine” is the title of a state-of-the-art lecture on Friday, Nov. 18.

Kevin J. Tracey, MD, is president and CEO of the Feinstein Institute for Medical Research, professor of neurosurgery and molecular medicine at Hofstra Northwell School of Medicine, and executive vice president for research at Northwell Health in Manhasset, NY.

The main focus of Dr. Tracey’s laboratory is the molecular basis of inflammation and the mechanism by which neurons control the immune system. His laboratory discovered the molecular mechanism for the neural control of inflammation, now termed the inflammatory reflex. This discovery led to the development of devices that use electrons delivered to neurons as a replacement for anti-inflammatory drugs—a new approach called bioelectronic medicine.

His lab participated in the first successful clinical trial demonstrating that vagus nerve stimulation can be effective in methotrexate-resistant rheumatoid arthritis patients.

An inventor with more than 60 US patents, Dr. Tracey is also cofounder of the Global Sepsis Alliance, a nonprofit organization supporting the efforts of 1 million caregivers in more than 70 countries to understand and combat sepsis. He is the author of Fatal Sequence and more than 320 scientific papers.

He has been inducted into the American Society of Clinical Investigation, the American Association of Physicians, and the Long Island Technology Hall of Fame, and is a fellow in the American Association for the Advancement of Science. His honors include an honorary degree from the Karolinska Institute, Stockholm, Sweden, and lectureships from Harvard, Yale, Rockefeller University, the National Institutes of Health, among others.

Dr. Tracey received his MD from Boston University. He trained in neurosurgery at the New York Hospital/Cornell University Medical Center, and was a guest investigator at the Rockefeller University. Since 1992, he has directed the Laboratory of Biomedical Science in Manhasset, where he was appointed president of the Feinstein Institute in 2005.

October/November 2016  (Vol 8, Issue 10/11)